Cargando…
The Emerging Role of Histone Deacetylase Inhibitors in Cervical Cancer Therapy
SIMPLE SUMMARY: Histone deacetylase inhibitors (HDACIs) are a relatively new drug class with important effects on the epigenetic regulation in cancer, inducing cancer cell death, apoptosis induction, and cell cycle arrest. Even though HDACIs have, to date, received approval for mainly hematologic ma...
Autores principales: | Psilopatis, Iason, Garmpis, Nikolaos, Garmpi, Anna, Vrettou, Kleio, Sarantis, Panagiotis, Koustas, Evangelos, Antoniou, Efstathios A., Dimitroulis, Dimitrios, Kouraklis, Gregory, Karamouzis, Michail V., Marinos, Georgios, Kontzoglou, Konstantinos, Nonni, Afroditi, Nikolettos, Konstantinos, Fleckenstein, Florian N., Zoumpouli, Christina, Damaskos, Christos |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10137219/ https://www.ncbi.nlm.nih.gov/pubmed/37190151 http://dx.doi.org/10.3390/cancers15082222 |
Ejemplares similares
-
Clinical Significance of the Histone Deacetylase 2 (HDAC-2) Expression in Human Breast Cancer
por: Garmpis, Nikolaos, et al.
Publicado: (2022) -
FDA-Approved Monoclonal Antibodies for Unresectable Hepatocellular Carcinoma: What Do We Know So Far?
por: Psilopatis, Iason, et al.
Publicado: (2023) -
The Role of Hyperthermic Intraperitoneal Chemotherapy in Uterine Cancer Therapy
por: Psilopatis, Iason, et al.
Publicado: (2023) -
Ovarian Torsion in Polycystic Ovary Syndrome: A Potential Threat?
por: Psilopatis, Iason, et al.
Publicado: (2023) -
Targeted Therapies for Hepatocellular Carcinoma Treatment: A New Era Ahead—A Systematic Review
por: Damaskos, Christos, et al.
Publicado: (2022)